C. Farley

发表

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer

J. Hainsworth, H. Burris, D. Yardley, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site

J. Hainsworth, H. Burris, D. Spigel, 2010, Cancer.

Paclitaxel/Carboplatin/Etoposide Versus Gemcitabine/Irinotecan in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site: A Randomized, Phase III Sarah Cannon Oncology Research Consortium Trial

J. Hainsworth, D. Spigel, F. Greco, 2010, Cancer journal.

Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer

J. Hainsworth, D. Spigel, J. Bearden, 2007, Cancer.

Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial.

J. Hainsworth, J. Sosman, L. Hart, 2007, Clinical genitourinary cancer.

Tracheoesophageal (TE) fistula development in a phase II trial of concurrent chemoradiation (CRT) and bevacizumab (B) in limited-stage small-cell lung cancer (LS-SCLC)

J. Hainsworth, L. Hart, H. Burris, 2008 .

Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.

J. Hainsworth, H. Burris, D. Yardley, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.

J. Hainsworth, H. Burris, J. Infante, 2009, Clinical breast cancer.

Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.

J. Hainsworth, H. Burris, D. Spigel, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.

J. Hainsworth, D. Spigel, F. Greco, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients (pts) with HER2-positive metastatic breast cancer (MBC)

J. Hainsworth, H. Burris, J. Infante, 2008 .

A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2008, Clinical breast cancer.

Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma

J. Hainsworth, D. Spigel, F. Greco, 2008, Cancer.

Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site

J. Hainsworth, H. Burris, D. Spigel, 2010, Cancer.

Weekly bortezomib in the treatment of patients (pts) with previously treated multiple myeloma: A phase II trial of the Minnie Pearl Cancer Research Network.

J. Hainsworth, R. Hermann, D. Spigel, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.